市场调查报告书
商品编码
1261647
2022-2028 年全球外科吻合器市场规模、份额、行业趋势分析报告(按类型、产品类型、最终用途、区域展望和预测)Global Surgical Stapling Devices Market Size, Share & Industry Trends Analysis Report By Type, By Product Type, By End-use, By Regional Outlook and Forecast, 2022 - 2028 |
外科吻合器市场规模预计到 2028 年将达到 79 亿美元,预测期内復合年增长率为 9.4%。
在许多情况下,外科医生可能需要了解最佳使用这些技术的科学或临床基础,或者如何从特定技术的特定优势中获益。 因此,即使设备运行良好,您也可能经常依赖外科医生的专业知识、判断力和轶事证据来获得更好的结果。
手术吻合器是最常用的手术器械之一,其技术几乎在不断发展。 儘管这些装置具有很强的适应性和实用性,但已经有充分记录的钉线洩漏导致术后困难的案例,其中许多是由于与缺血无关的问题。
外科吻合器越来越重要,尤其是在妇科、胃肠、减肥等高难度手术中。 此外,外科缝合器械的使用促进了新外科技术的发展、现有外科技术的改进和改善的临床结果。 全球对微创治疗的需求不断增长,正在推动外科缝合设备市场的扩张。
COVID-19 影响分析
许多医院被迫暂停非紧急门诊服务,这对手术吻合器市场产生了重大影响。 社会排斥、人口控制和诊所准入限制对市场产生了重大影响。 然而,由于主要製造商专注于引进技术先进的产品以增加市场份额,因此在解除限制后市场预计将大幅增长。 我们还认为,随着生产重回正轨、手术恢復和需求上升,手术吻合器市场将在大流行之后再次开始扩张。
市场增长因素
外科吻合器的技术改进
外科缝合钉和相关缝合钉的技术发展对医疗保健专业人员对外科缝合装置的接受度产生了重大影响。 自从引入动力外科缝合器以来,闭合术后伤口所需的时间已经减少,从而最大限度地减少了问题和出血。 在临床试验中,动力手术吻合器在癒合速度和不适感方面表现更好。 因此,手术吻合器提供的技术优势有望推动市场增长。
慢性病患病率上升
由于近年来癌症等慢性病的增加,到门诊手术设施就诊的患者人数也有所增加。 此外,由于患者选择腹腔镜治疗的增加,预计在整个预测期内,外科缝合器市场将增长。 成本下降、住院时间缩短以及腹腔镜手术的日益普及都归因于这些因素。 因此,由于慢性病的高患病率和腹腔镜手术的日益普及,预计手术吻合器的市场增长将激增。
市场製约因素
外科吻合器的常见问题
在伤口部位打开订书钉线、订书钉密封不良缺陷、订书钉缺陷或卡纸、订书钉未从订书机射出、订书钉未正确放置在错误的组织中、特定应用使用错误尺寸的订书钉等,都是一些使用装订设备的常见问题。 这些问题的频繁发生导致钉伤、更长的癒合时间以及更高的患者医疗和康復成本。 这些问题预计将限制吻合器的市场扩张。
产品类型展望
根据产品类型,外科吻合设备市场分为电动和手动。 到 2021 年,动力部分在手术吻合器市场中占据了很大的收入份额。 这是由于无需体力即可方便地闭合伤口。 医疗保健专业人员现在可以通过各种尺寸的机动手术吻合器获得更多选择。 此外,技术进步、产品发布以及公司对开发动力装订设备的关注也是预计推动这一领域增长的因素之一。
按类型划分的前景
按类型划分,手术吻合器市场分为一次性和可重复使用。 2021 年,可重复使用部分将占手术吻合器械市场的最高收入份额。 这是因为可重复使用的手术吻合器在消毒后可用于多名患者。 由于该产品成本低,预计该类别在发展中国家占有更大份额。 此外,手术吻合器与可吸收吻合器相结合的引入预计将在预测期内推动该细分市场的扩张。
结束使用 Outlook
按最终用途,外科缝合设备市场分为医院和门诊手术中心。 2021 年,医院部门在手术吻合器市场中的收入份额最大。 这是因为医院看到的主要趋势表明转向了包括机器人手术在内的临床效率模型。 微创手术可以受益于机器人手术。 医院拥有训练有素的员工和高科技设备,以确保安全和成功的程序。 由于不同方法的有利报销条款,预计医院类别在预测期内也将保持其主导地位。
区域展望
按地区划分,对北美、欧洲、亚太地区和拉美地区的手术吻合器市场进行了分析。 2021 年,北美地区在手术吻合器市场的收入份额最高。 这是由于随着手术总数的增加,尖端技术和微创手术的采用。 此外,世界上肥胖率最高的流行病、跨国公司在当地的存在以及政府对微创手术的批准也有助于占据重要的市场份额。
市场进入者采取的主要策略是产品发布。 根据 Cardinal Matrix 中的分析,Johnson & Johnson (Ethicon) 是外科吻合器市场的领导者。 Intuitive Surgical, Inc.、Medtronic PLC 和 Stryker Corporation 等公司是外科吻合器市场的领先创新者。
The Global Surgical Stapling Devices Market size is expected to reach $7.9 billion by 2028, rising at a market growth of 9.4% CAGR during the forecast period.
Surgical stapling devices apply surgical staples instead of sutures to heal skin wounds or keep tissue together. When operating time is an issue and aesthetic closure is not a top priority, surgical staples may help close injuries quickly. There are now three main categories of mechanical staplers for open and endoscopic surgery: linear, circular, and endoscopic surgical staplers.
Several novel surgical equipment and gadgets are now available because of technological advancements in various scientific fields. To enhance patient outcomes, surgeons can create novel surgical procedures due to the constant introduction of new instruments and the ongoing technological advances in already-existing technologies.
In many instances, surgeons may need to learn the scientific or clinical foundation for the best use of these technologies or how to benefit from any particular advantages a specific technology may have. So, even if the devices work well, surgeons may often depend on their expertise, judgment, or anecdotal evidence for better results.
Equipment that is often employed during surgical operations and is also undergoing a nearly continual state of technological evolution is the surgical stapler. While these tools are adaptable and practical, there have been well-reported instances of staple line leaks that resulted in postoperative difficulties, many of which were caused by problems unrelated to ischemia.
In operations, particularly challenging ones like gynecologic, gastrointestinal, & bariatric procedures, surgical stapling instruments are becoming more and more crucial. In addition, the use of surgical stapling devices facilitates the development of novel surgical techniques, the alteration of existing procedures, and the enhancement of clinical results. The increasing demand for less invasive treatments globally drives the expansion of the surgical stapling devices market.
COVID-19 Impact Analysis
The lockdown compelled many hospitals to stop their outpatient departments for situations other than emergencies, which had a significant impact on the market for surgical stapling devices. Social exclusion, population control, and restricted clinic access substantially influenced the market. However, the market is anticipated to grow significantly after the lockdown restrictions are lifted as significant manufacturers are concentrating on introducing technologically cutting-edge items to increase their market share. Also, with production getting back on track, and the resume in surgical procedures which is increasing the demand, the surgical stapling devices market will start to expand again after the pandemic.
Market Growth Factors
The technological betterment of surgical stapling devices
Technological developments in surgical staples and related staples have significantly impacted the acceptance of surgical stapling devices by healthcare practitioners. With the introduction of powered surgical staplers, the time needed to seal the wound after surgery has decreased, minimizing problems and blood loss. In clinical testing, the powered surgical stapler performed better in the speed of healing and decreased discomfort. Hence, it is anticipated that the technical benefits offered by surgical stapling devices will drive market growth.
Rising prevalence of chronic diseases
Due to the rise in chronic illnesses like cancer during the last several years, there has also been an increase in the number of visits to ambulatory surgical facilities. Moreover, it is predicted that the market for surgical staplers will grow throughout the projection years due to the rise in laparoscopic treatments chosen by patients. The decreasing cost, shorter hospital stays, and increasing popularity of laparoscopic operations are all due to these factors. Hence with the high prevalence of chronic cases and the rising popularity of laparoscopic operations, the market growth for surgical stapling devices will surge.
Market Restraining Factors
Common issues with surgical staplers
Opening of the staple line at a wound site, faulty staples that result in insufficient sealing, defective or jammed staplers, failing to shoot a staple from a stapler, staples that were improperly positioned on the wrong tissue spot using a staple that is the incorrect size for a particular application are some of the common issues associated with the usage of stapling devices. These frequent issues may result in surgical staple wounds, lengthening healing time and exposing the patient to higher medical and rehabilitation expenses. These issues with the stapling devices are expected to restrict their market expansion.
Product Type Outlook
Based on product type, the surgical stapling devices market is segmented into powered and manual. The powered segment acquired a significant revenue share in the surgical stapling devices market in 2021. This is due to their simplicity of wound closure without requiring physical effort. Medical professionals now have more options due to the availability of powered surgical stapling devices in various sizes. In addition, the escalating technical advancements, product launches, and firms' increased emphasis on developing powered stapling devices are among other factors which are anticipated to boost the segment growth.
Type Outlook
On the basis of type, the surgical stapling devices market is divided into disposable and reusable. The reusable segment held the highest revenue share in the surgical stapling devices market in 2021. This is because reusable surgical stapling instruments may be used on several patients after sterilizing. Due to the product's low cost, the category is expected to have a bigger share in developing countries. Furthermore, the introduction of surgical stapling devices combined with absorbable staplers is projected to boost the segment expansion in the projected period.
End Use Outlook
By end-use, the surgical stapling devices market is classified into hospitals and ambulatory surgical centers. The hospitals segment witnessed the largest revenue share in the surgical stapling devices market in 2021. This is because hospitals are seeing a significant trend that points to a move towards clinical efficiency models, including robotic surgery. Minimally invasive procedures benefit from robotic surgery. The hospitals have well-trained staff and high-tech devices, which ensures a safe and successful procedure. Also, the hospital category is anticipated to maintain its dominance due to favorable reimbursement conditions for different methods during the projection period.
Regional Outlook
Region-wise, the surgical stapling devices market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region registered the highest revenue share in the surgical stapling devices market in 2021. This is owing to the employment of cutting-edge technology and minimally invasive procedures with the rising number of total operations. In addition, the greatest obesity prevalence in the world, the local presence of multinational corporations, and the government's clearance for minimally invasive operations are other factors contributing to the large market share.
The major strategies followed by the market participants are Product Launches. Based on the Analysis presented in the Cardinal matrix; Johnson & Johnson (Ethicon, Inc.) is the forerunner in the Surgical Stapling Devices Market. Companies such as Intuitive Surgical, Inc., Medtronic PLC, and Stryker Corporation are some of the key innovators in Surgical Stapling Devices Market.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Stryker Corporation, Medtronic PLC, BioPro, Inc., ConMed Corporation, Smith & Nephew PLC, Intuitive Surgical, Inc., Johnson & Johnson (Ethicon, Inc.), B. Braun Melsungen AG, Becton, Dickinson and Company and Meril Life Science Private Limited.
Recent Strategies Deployed in Surgical Stapling Devices Market
Product Launches and Expansions:
Jun-2022: Ethicon, part of Johnson & Johnson introduced the ECHELON 3000 Stapler intended to use in resection, transection, and creation of anastomoses. The ECHELON 3000 is available in 45mm and 60mm staplers. The new stapler is a single-patient-use, sterile, that can cut and staple both at the same time.
May-2022: Stryker introduced the EasyFuse Dynamic Compression System, which will be a part of Stryker's foot and ankle product portfolio. The new staple system is developed using a nickel-titanium alloy metal, known as nitinol. The EasyFuse Dynamic Compression System decreases complexity in surgeries. The newly launched product features, a wide staple bridge, an intuitively developed inserter, and sterile-packed instrumentation.
Jun-2021: Intuitive unveiled SureForm, a robotic-assisted surgical stapler SureForm. The surgical stapler comes with SmartFire technology, an integrated software. The SureForm allows the surgeon to simultaneously fire the stapler from the console itself, and perform the RAS procedure. Further, the launch of the robot-assisted stapler reflects the company's advancement towards simplification of the surgery procedure.
Mar-2021: Ethicon, part of Johnson & Johnson launched ECHELON+ Stapler equipped with Gripping Surface Technology (GST) Reloads. The new surgical stapler is developed to enhance staple line security, and lower complications. The stapler is equipped with a new motor with dynamic firing and a restructured ECHELON+Anvil.
Dec-2020: Medtronic launched Tri-Staple EEA Circular Stapler in India. The 3-row circular stapler is equipped with Medtronic's Tri-Staple technology and has multiple height staples. The new circular stapler is intended to use in colorectal procedures. Additionally, the device is also equipped with enhanced tactile and audible feedback that allows clinicians to make a better informed decisions in the operating room.
Feb-2020: Smith+Nephew introduced the CORI Surgical system. The new surgical systems are intended to enhance outcomes during knee arthroplasty, and also increase accuracy. Additionally, the CORI system is portable and easy to move from one theatre to the other.
Geographical Expansions:
Nov-2022: Becton, Dickinson, and Company (BD) expanded its global footprint by setting up a new manufacturing facility in Tijuana, Mexico. The new facility would primarily manufacture devices and technologies. The establishment of the new facility demonstrates BD's devotion to Mexico and its strong relationship with communities across Mexico. This new plant would further simplify BD's operations by integrating a distribution center, a manufacturing site, and the transportation of products to the end consumer all in one place.
Aug-2022: Stryker opened a new facility in Ireland. The new high-tech facility is a 156,000-square-foot facility, which would reinforce the company's market position in additive manufacturing.
Jun-2022: Smith+Nephew opened a new manufacturing and R&D facility in Hull, United Kingdom. The new facility is intended for its advanced wound management franchise. The establishment of the new facility reflects the company's commitment to the UK and to building a leading market position in advanced wound management.
Jun-2022: Stryker expanded its global footprint by setting up a new R&D facility in Haryana, India. The new 150,000-square-foot facility would advance innovation. Further, Stryker's Global Technology Centre (SGTC) reinforces the company's potential to develop and design new products and solutions.
Trials and Approvals:
Dec-2021: Intuitive received FDA approval for its SureForm 30. SureForm 30 is an 8 mm curved-tip stapler. The curved stapler is intended to use in thoracic, general, pediatric, urologic, and gynecologic surgeries.
Acquisitions and Mergers:
Sep-2022: B. Braun took over Clik-FIX Catheter Securement Devices from Starboard Medical. The acquisition includes a Clik-FIX Peripheral catheter securement device, Clik-FIX Universal catheter securement device, a Clik-FIX Neonatal PICC catheter securement device, and Clik-FIX PICC/Central catheter securement device. The combination of the Clik-FIX portfolio and B.Braun's competence and deep knowledge enables the acquirer to fulfill the growing needs of its clients and further strengthens its market position in the IV therapy market.
Nov-2020: Medtronic took over Medicrea, a France-based company primarily into developing, manufacturing, and marketing orthopedic implants intended for spinal surgery. This acquisition would reinforce Medtronic's position in personalized implants' AI-based prediction and planning capabilities.
Partnerships, Collaborations and Agreements:
May-2022: Intuitive teamed up with Creo Medical Group, a UK-based medical device company. The collaboration includes optimizing Creo's products to make them consistent with Intuitive's robotic technology.
Market Segments covered in the Report:
By Type
By Product Type
By End-use
By Geography
Companies Profiled
Unique Offerings from KBV Research
List of Figures